Experimental and clinical nephroprotection by the xanthine oxidase inhibitor febuxostat

Naunyn Schmiedebergs Arch Pharmacol. 2016 Aug;389(8):815-7. doi: 10.1007/s00210-016-1260-4. Epub 2016 May 25.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Enzyme Inhibitors
  • Febuxostat*
  • Gout Suppressants
  • Humans
  • Thiazoles
  • Xanthine Oxidase*

Substances

  • Enzyme Inhibitors
  • Gout Suppressants
  • Thiazoles
  • Febuxostat
  • Xanthine Oxidase